Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy

Title
Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy
Authors
Keywords
α-galactosylceramide, chemo-immunotherapy, combined strategy, immunosuppression, PD-L1 antibody
Journal
AAPS Journal
Volume 21, Issue 2, Pages -
Publisher
Springer Nature
Online
2019-01-12
DOI
10.1208/s12248-018-0289-3

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started